Evidence-Based Hair
Playback speed
10 seconds
Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
By
Evidence-Based Hair
FEATURING
Jeff Donovan
By
Evidence-Based Hair
FEATURING
Jeff Donovan
0 views
April 7, 2023
Comments 0
Login to view comments.
Click here to Login
Videos